← Leaderboards
Celina G Kleer
University Of Michigan At Ann Arbor
$13,464,529
Attributed
$14,062,069
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,062,069 · 5
By mechanism
R01$11,701,403 · 3
U01$1,681,966 · 1
K08$678,700 · 1
Top collaborators
- Xueding Wang3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Paul B Watkins$20,798,906
- Cheng-Yu Lee$6,469,104
- Bethany S Strunk$924,984
- Timothy Louis Frankel$4,183,486
- Yi Sun$9,791,676
Others in their field
Top investigators on “Neoplasm Metastasis”
- Charles A Coltman · Southwest Oncology Group$110,022,912
- Timothy J Eberlein · Washington University$54,581,241
- Samuel A Wells · Duke University$31,864,469
- William George Nelson · Johns Hopkins University$31,104,956
- Zaver M Bhujwalla · Johns Hopkins University$30,433,864
- Leonidas C Platanias · University Of Illinois At Chicago$30,290,986
Research focus
Neoplasm MetastasisIn VivoTumorMalignant Breast NeoplasmCarcinomaWomanBreast Cancer CellPathway InteractionsBreastMammary Gland ParenchymaMouse ModelTissuesIn VitroLaboratoriesFollow-UpCohortProteinsMediatingCessation Of LifeMalignant NeoplasmsMammary EpitheliumFundingBreast CarcinomaInvaded
Grant awards (46)
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)$456,475
R01 · FY2025 · CA
Role of EZH2 in Breast Cancer Progression$453,180
R01 · FY2025 · CA · contact PI
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)$524,929
R01 · FY2024 · CA
Role of EZH2 in Breast Cancer Progression$430,520
R01 · FY2024 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$453,180
R01 · FY2023 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$370,500
R01 · FY2023 · CA · contact PI
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)$213,677
R01 · FY2023 · CA
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$363,090
R01 · FY2022 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$370,500
R01 · FY2021 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$370,500
R01 · FY2020 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$294,500
R01 · FY2020 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$370,500
R01 · FY2019 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$285,665
R01 · FY2019 · CA · contact PI
Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.$349,875
R01 · FY2018 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$294,500
R01 · FY2018 · CA · contact PI
Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.$349,875
R01 · FY2017 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$294,500
R01 · FY2017 · CA · contact PI
Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.$349,875
R01 · FY2016 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$294,500
R01 · FY2016 · CA · contact PI
Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.$349,875
R01 · FY2015 · CA · contact PI
Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.$349,875
R01 · FY2014 · CA · contact PI
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af$327,573
U01 · FY2014 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$263,631
R01 · FY2014 · CA · contact PI
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af$318,655
U01 · FY2013 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$255,477
R01 · FY2013 · CA · contact PI
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af$340,325
U01 · FY2012 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$293,575
R01 · FY2012 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$274,785
R01 · FY2012 · CA · contact PI
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af$341,695
U01 · FY2011 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$293,575
R01 · FY2011 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$271,494
R01 · FY2011 · CA · contact PI
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af$353,718
U01 · FY2010 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$302,655
R01 · FY2010 · CA · contact PI
Role of EZH2 in Breast Cancer Progression$278,389
R01 · FY2010 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$302,655
R01 · FY2009 · CA · contact PI
Role of EZH2 in Breast Cancer$267,657
R01 · FY2009 · CA · contact PI
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer$302,655
R01 · FY2008 · CA · contact PI
Role of EZH2 in Breast Cancer$257,343
R01 · FY2008 · CA · contact PI
Role of EZH2 in Breast Cancer$255,943
R01 · FY2007 · CA · contact PI
Role of LIBC in Inflammatory Breast Cancer Phenotype$135,720
K08 · FY2007 · CA · contact PI
Role of EZH2 in Breast Cancer$241,924
R01 · FY2006 · CA · contact PI
Role of LIBC in Inflammatory Breast Cancer Phenotype$135,730
K08 · FY2006 · CA · contact PI
Role of EZH2 in Breast Cancer$249,554
R01 · FY2005 · CA
Role of LIBC in Inflammatory Breast Cancer Phenotype$135,740
K08 · FY2005 · CA
Role of LIBC in Inflammatory Breast Cancer Phenotype$135,750
K08 · FY2004 · CA
Role of LIBC in Inflammatory Breast Cancer Phenotype$135,760
K08 · FY2003 · CA